RMD
$250.80-0.95%
as of close, Oct 27, 2026
☾ AH $250.80 -0.95%
RMD — ResMed Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDED
60.080.0100.0120.0140.0160.0180.0200.0220.0240.0260.0280.0020.0M$250.80—20162019202120242026
2026-10-27
Price$250.80
MA20$217.54
MA50$237.05
Vol4.7M
Key stats#
Price data
- Price
- $250.80
- YTD price return
- +4.12%
- YTD total return
- +4.97%
- Next earnings
- Oct 29, 2026 · After close
- Market cap
- 36.2B
- Enterprise value
- 35.5B
- Shares outstanding
- 144.3M
- 52W low
- $180.27
- 52W high
- $277.67
- From 52W high
- -9.68%
- From 52W low
- +39.12%
- 52W range
- 72%
- Beta
- 0.75
Volume
- Rel volume
- 0.78×
- 30D volume
- 1.2M
- 30D $ vol
- 272.6M
Insider trading
- Insider net 1W
- −$102K
- Insider net 1M
- −$1.2M
- Insider net 3M
- −$5.4M
- Insider net 1Y
- −$16.5M
Form 4 transactions by trade date, as filed; latest on file 2026-10-23.
Fundamentals
- Sales (ttm)
- 5.7B
- Sales/share
- $39.19
- EPS (ttm)
- $10.43
- FCF (ttm)
- 1.6B
- FCF/share
- $11.44
- Book value/share
- $45.65
- Net margin
- 26.94%
- ROE
- 23.13%
- ROA
- 16.99%
- Debt / equity
- 0.06×
- Current ratio
- 3.10
Growth (CAGR, ttm) · 10Y
- Sales
- +9.86%+10.21%+12.08%+11.89%
- Net income
- +8.76%+19.28%+26.28%+15.77%
- FCF
- -0.73%+42.19%+21.08%+12.92%
- Shares
- -1.48%-0.64%-0.20%+0.25%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +9.68%+19.64%+26.35%+15.40%
- Sales/share
- +11.51%+10.92%+12.30%+11.61%
- FCF/share
- +0.76%+43.11%+21.32%+12.64%
- Book value/share
- +12.01%+17.58%+18.18%+14.25%
- Dividend/share
- +13.22%+10.89%+9.00%+7.18%
- Price
- -3.25%+23.03%-1.33%+15.27%
- Total return
- -2.22%+24.25%-0.43%+16.55%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 24.0×
- P/OI (ttm)
- 19.2×
- Fwd P/E
- 19.1×
- P/S (ttm)
- 6.4×
- P/B (mrq)
- 5.5×
- P/FCF (ttm)
- 21.9×
- EV/EBITDA (fy)
- 17.0×
- EV/Sales (ttm)
- 6.3×
- FCF yield (ttm)
- 4.56%
- Dividend yield (fwd)
- 1.05%
- Dividend yield (ttm)
- 0.98%
- Dividend/share (fwd)
- $2.64
- Buyback yield (realized, 1y)
- 1.48%
- Shareholder yield (realized, 1y)
- 2.40%
- Buyback yield (cash, ttm)
- 1.73%
- Shareholder yield (cash, ttm)
- 2.70%
Vs own 10Y history
- P/E
- 8th
- P/OI
- 8th
- P/S
- 26th
- P/B
- 14th
- P/FCF
- 13th
Bar = where today’s multiple sits in RMD’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
-0.95%
5D
+2.16%
1M
+12.97%
3M
+23.50%
YTD
+4.12%
1Y
-3.24%
5Y
-6.46%
Recent filings#
All filings and insider trades →Financial statements
Open full RMD financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
